Prehab for Pancreatic Cancer Surgery

Part of paid clinical trials in Worester, Massachusetts.

Sponsor
University of Massachusetts, Worcester
Study ID
NCT07478185
Status
Recruiting
Apply to this trial

Conditions

  • Pancreatic Cancer, Adult
  • Prehabilitation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Multimodal Prehabilitation — BEHAVIORAL
    Participants will receive a structured, multimodal prehabilitation program delivered during neoadjuvant chemotherapy prior to planned pancreatic cancer surgery. The program integrates supervised, individualized exercise training, nutritional assessment and counseling with recommended preoperative immunonutrition, and supportive care focused on symptom management and functional support. Prehabilitation is delivered as an integrated component of preoperative care and continues through completion of neoadjuvant therapy until surgery.

Study Details

The goal of this clinical study is to test whether a structured prehabilitation program can be successfully used by adults with pancreatic cancer who are receiving chemotherapy before planned surgery. Prehabilitation is a program designed to improve a person's physical fitness, nutrition, and symptom control before surgery. The study's main hypothesis is that patients with pancreatic cancer can take part in and adhere to a multimodal prehabilitation program during chemotherapy, and that doing so may improve physical function, patient experience, and early recovery after surgery.

Key Dates

Start date
Mar 31, 2026
Status verified
Apr 2026
Primary completion
Feb 29, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Multimodal Prehabilitation Program
    Participants in this single-arm study will receive a structured prehabilitation program during neoadjuvant chemotherapy prior to planned pancreatic cancer surgery.

Primary Outcome Measure

Feasibility of prehabilitation program delivery [ Time Frame: From enrollment through completion of neoadjuvant therapy (approximately 3-6 months) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UMass Memorial Medical CenterWoresterMassachusetts01655
Kayla R Widdowson, MD
[email protected]
774-641-1257

Find similar trials in Worester, MA

By research site
UMass Memorial Medical Center· Worester, MA

Related Studies